TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial
Crossref DOI link: https://doi.org/10.1007/s00280-014-2568-8
Published Online: 2014-08-31
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Erhardt, Andreas
Kolligs, Frank
Dollinger, Matthias
Schott, Eckart
Wege, Hennig
Bitzer, Michael
Gog, Christiane
Lammert, Frank
Schuchmann, Markus
Walter, Clemens
Blondin, Dirk
Ohmann, Christian
Häussinger, Dieter
Text and Data Mining valid from 2014-08-31